Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Ainos Inc. (AIMD)

  • Business News
  • Sept. 08, 2025, 13:30 UTC
  • 1
  • 0 comments

Ainos to Showcase AI Nose at SEMICON Taiwan 2025

Market reaction Comment Full text

Nutex Health Inc (NUTX)

  • Business News
  • Sept. 08, 2025, 13:15 UTC
  • 1
  • 0 comments

GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.

Market reaction Comment Full text

TNF Pharmaceuticals, Inc. (TNFA)

  • Business News
  • Sept. 08, 2025, 13:15 UTC
  • 1
  • 0 comments

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Market reaction Comment Full text

Femasys Inc (FEMY)

  • Business News
  • Sept. 08, 2025, 13:03 UTC
  • 1
  • 0 comments

- Femasys Secures Regulatory Approval for FemBloc®Permanent Birth Control in New Zealand

Market reaction Comment Full text

Amicus Therapeutics Inc (FOLD)

  • Business News
  • Sept. 08, 2025, 13:02 UTC
  • 1
  • 0 comments

New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM

Market reaction Comment Full text

Medicinova Inc (MNOV)

  • Business News
  • Sept. 08, 2025, 13:00 UTC
  • 1
  • 0 comments

MediciNova Provides Shareholder Update on Key Developments

Market reaction Comment Full text

Bristol-Myers Squibb Co. (BMYMP)

  • Business News
  • Sept. 08, 2025, 13:00 UTC
  • 1
  • 0 comments

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Market reaction Comment Full text

Summit Plc (SMMT)

  • Business News
  • Sept. 08, 2025, 12:46 UTC
  • 1
  • 0 comments

Summit Plc - Current report filing

Market reaction Comment Full text

ImmunityBio Inc (IBRX)

  • Business News
  • Sept. 08, 2025, 12:32 UTC
  • 0
  • 0 comments

ImmunityBio’s ANKTIVA® Reverses Lymphopenia and Extends Overall Survival in Patients With Advanced Non-Small Cell Lung Cancer Resistant to Checkpoint Therapy

Market reaction Comment Full text

Dentsply Sirona Inc (XRAY)

  • Business News
  • Sept. 08, 2025, 12:32 UTC
  • 0
  • 0 comments

Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives

Market reaction Comment Full text
  • Previous
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next

Search

News categories

  • Technical Exchange News(9979)
  • Event(412)
  • SEC News(169136)
  • FDA Approval(9386)
  • Company Report(721)
  • Business News(112722)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin